| 摘要 |
The invention describes compounds of formula Iwhere radical values are provided in the description, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFRα and PDGFR&bgr; kinases. |
